| Followers | 390 |
| Posts | 18088 |
| Boards Moderated | 1 |
| Alias Born | 03/07/2014 |
Wednesday, February 22, 2017 12:31:32 PM
Quote LOL, "I'll have to revisit but I recall another stem cell company with CD conversions but if I recall correctly they were purchased for 349Ma Ma Million Dollars!! LOLzzz AS in "PAST TENSE" YA let's revisit that info and compare to here. Would very interesting, YA THINK!? USRM Stem Cell spent 125 Ma Ma MILLIONS on R&D per their website.. so how do you compare a few 100K CD here and there WITH with BIG MONEY? Sounds like PURE BS!! IMO "
Yeah, ya better do a little SEC FILING READING IMO. Cause you're not even close to correct.
This company hasn't seen ANY "big money", aka the $125 MILLION sunk into this loss pit, since the PRE-IPO DAYS and "maybe' to about the end of 2009, that's EIGHT FREAKING YEARS AGO, MOST of the coin coming in prior to , or just shortly after the IPO. After that, COMPLETELY DOWN HILL, nothing but dire financial condition and "GOING CONCERN" on life support.
http://www.bizjournals.com/southflorida/stories/2010/09/27/daily54.html
MOST of the $125 mil or whatever it was, was raised from early stage investors, by Howard Leonhardt convincing them to "get in" before the damn IPO, an IPO that was a complete bust. Those early investors have lost nearly ever last CENT they ever sunk into this POS. Dan Marino among others. Leonhardts ex-wife had to SUE THE DAMN COMPANY recently, still trying to get paid back the money she lent this money pit sink hole.
They went public in 2008 in a disaster of an IPO. Almost ONE YEAR to thee day, as fast as could happen, they were DE-LISTED FROM THE NASDAQ and sent to the OTC, forever. They've been a "GOING CONCERN" and on cash life support and living on toxic convertible debt ever since. They've NEVER, EVER, EVER since attracted any "big money" or major financing deals and their key clinical trials ALL stalled-out ended around 2009/2010 for LACK OF FUNDING as they exhausted their last gasp cash, laid off almost the entire company, and became a literal 3 or 4 person company, operating out of a tiny leased office "suite" in Florida, where they are to this day. READ THEIR HISTORY and SEC FILING FACTS.
http://venturebeat.com/2008/02/20/bioheart-a-new-record-for-ipo-futility/
http://venturebeat.com/2008/02/19/three-yards-and-a-cloud-of-dust-bioheart-makes-it-across-the-ipo-goal-line-but-with-little-to-show-for-its-struggles/
https://globenewswire.com/news-release/2009/02/26/393349/160467/en/Bioheart-Inc-Receives-Notice-of-Delisting-From-The-NASDAQ-Capital-Market.html
http://www.bizjournals.com/southflorida/stories/2010/07/26/daily1.html
Their big LOAN DEFAULT, collapse from then on.
http://lawsuitpressrelease.com/investors-sue-bioheart-inc-millions-unpaid-debt
And on and on and on and on......DO SOME FREAKING HOMEWORK, eh.
This ain't no OCATA, LOL !! Not by any stretch of a bad imagination, LOL ! USRM spent $125 million and what do they have to show for it? DEBTS and NO PATENT left on their key product and borrowing toxic debt in chunks of $50K at a time to stay alive and SOLVENT. BILLIONS of dilution shares issued. 99% LOSSES to their common shares.
THAT is not the OCATA "story", not by a million miles. PURE BS "trying" to hype this into some OCATA "buy-out" bull crap story IMO.
Yeah, ya better do a little SEC FILING READING IMO. Cause you're not even close to correct.
This company hasn't seen ANY "big money", aka the $125 MILLION sunk into this loss pit, since the PRE-IPO DAYS and "maybe' to about the end of 2009, that's EIGHT FREAKING YEARS AGO, MOST of the coin coming in prior to , or just shortly after the IPO. After that, COMPLETELY DOWN HILL, nothing but dire financial condition and "GOING CONCERN" on life support.
http://www.bizjournals.com/southflorida/stories/2010/09/27/daily54.html
MOST of the $125 mil or whatever it was, was raised from early stage investors, by Howard Leonhardt convincing them to "get in" before the damn IPO, an IPO that was a complete bust. Those early investors have lost nearly ever last CENT they ever sunk into this POS. Dan Marino among others. Leonhardts ex-wife had to SUE THE DAMN COMPANY recently, still trying to get paid back the money she lent this money pit sink hole.
They went public in 2008 in a disaster of an IPO. Almost ONE YEAR to thee day, as fast as could happen, they were DE-LISTED FROM THE NASDAQ and sent to the OTC, forever. They've been a "GOING CONCERN" and on cash life support and living on toxic convertible debt ever since. They've NEVER, EVER, EVER since attracted any "big money" or major financing deals and their key clinical trials ALL stalled-out ended around 2009/2010 for LACK OF FUNDING as they exhausted their last gasp cash, laid off almost the entire company, and became a literal 3 or 4 person company, operating out of a tiny leased office "suite" in Florida, where they are to this day. READ THEIR HISTORY and SEC FILING FACTS.
http://venturebeat.com/2008/02/20/bioheart-a-new-record-for-ipo-futility/
http://venturebeat.com/2008/02/19/three-yards-and-a-cloud-of-dust-bioheart-makes-it-across-the-ipo-goal-line-but-with-little-to-show-for-its-struggles/
https://globenewswire.com/news-release/2009/02/26/393349/160467/en/Bioheart-Inc-Receives-Notice-of-Delisting-From-The-NASDAQ-Capital-Market.html
http://www.bizjournals.com/southflorida/stories/2010/07/26/daily1.html
Their big LOAN DEFAULT, collapse from then on.
http://lawsuitpressrelease.com/investors-sue-bioheart-inc-millions-unpaid-debt
And on and on and on and on......DO SOME FREAKING HOMEWORK, eh.
This ain't no OCATA, LOL !! Not by any stretch of a bad imagination, LOL ! USRM spent $125 million and what do they have to show for it? DEBTS and NO PATENT left on their key product and borrowing toxic debt in chunks of $50K at a time to stay alive and SOLVENT. BILLIONS of dilution shares issued. 99% LOSSES to their common shares.
THAT is not the OCATA "story", not by a million miles. PURE BS "trying" to hype this into some OCATA "buy-out" bull crap story IMO.
Posts are only my amateur opinions, personal views and thoughts. They are not any type of investment advice. Do one's own due diligence.
